A new osteoporosis drug could be on the market soon to help the millions of people suffering from a disease that has made the above catchphrase so annoyingly famous. It’s called abaloparatide, it’s being developed by Radius Pharmaceuticals, and it’s set to compete with Eli Lilly’s Forteo—the only other drug on the market of its type, currently sporting a monthly price tag of your left kidney. In fact, abaloparatide may actually be more effective than Forteo in bone repair, all without that pesky cancer side-effect in lab rats. Although highly anticipated, pricing is yet to be decided. For patients who cannot afford the current option (and insurers who decide not to cover), an affordable drug will be a godsend for hipbones and spinal columns around the world.